BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Alma HJ, de Jong C, Jelusic D, Wittmann M, Schuler M, Sanderman R, Schultz K, Kocks J, van der Molen T. Thresholds for clinically important deterioration versus improvement in COPD health status: results from a randomised controlled trial in pulmonary rehabilitation and an observational study during routine clinical practice. BMJ Open 2019;9:e025776. [PMID: 31256021 DOI: 10.1136/bmjopen-2018-025776] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Alma H, de Jong C, Kocks J, van der Molen T. Commentary: "Healthcare Professionals' Preferred Efficacy Endpoints and Minimal Clinically Important Differences in the Assessment of New Medicines for Chronic Obstructive Pulmonary Disease" by Dankers M et al. in Frontiers in Pharmacology 2020; 10: 1519. Front Pharmacol 2020;11:827. [PMID: 32581793 DOI: 10.3389/fphar.2020.00827] [Reference Citation Analysis]
2 Rabe KF, Chalmers JD, Miravitlles M, Kocks JWH, Tsiligianni I, de la Hoz A, Xue W, Singh D, Ferguson GT, Wedzicha J. Tiotropium/Olodaterol Delays Clinically Important Deterioration Compared with Tiotropium Monotherapy in Patients with Early COPD: a Post Hoc Analysis of the TONADO® Trials. Adv Ther 2021;38:579-93. [PMID: 33175291 DOI: 10.1007/s12325-020-01528-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
3 Marth K, Renner A, Pohl W. TRICOP - A Real-world effectiveness study with a single-inhaler extrafine triple therapy over 52 weeks in Austrian patients with COPD. Respir Med 2021;182:106398. [PMID: 33901786 DOI: 10.1016/j.rmed.2021.106398] [Reference Citation Analysis]
4 Rehman AU, Shah S, Abbas G, Harun SN, Shakeel S, Hussain R, Hassali MAA, Rasool MF. Assessment of risk factors responsible for rapid deterioration of lung function over a period of one year in patients with chronic obstructive pulmonary disease. Sci Rep 2021;11:13578. [PMID: 34193949 DOI: 10.1038/s41598-021-92968-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Koolen EH, van den Borst B, de Man M, Antons JC, Robberts B, Dekhuijzen PNR, Vercoulen JH, van den Heuvel M, Spruit MA, van der Wees PJ, van 't Hul AJ. The clinical effectiveness of the COPDnet integrated care model. Respir Med 2020;172:106152. [PMID: 32956973 DOI: 10.1016/j.rmed.2020.106152] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Alma H, de Jong C, Jelusic D, Wittmann M, Schuler M, Kollen B, Sanderman R, Kocks J, Schultz K, van der Molen T. Baseline health status and setting impacted minimal clinically important differences in COPD: an exploratory study. J Clin Epidemiol 2019;116:49-61. [PMID: 31362055 DOI: 10.1016/j.jclinepi.2019.07.015] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]